These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21421111)

  • 21. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
    Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
    JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatic analysis of the effects and mechanisms of decitabine and cytarabine on acute myeloid leukemia.
    Zhou S; Liu P; Zhang H
    Mol Med Rep; 2017 Jul; 16(1):281-287. PubMed ID: 28498449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons.
    Yuan E; Haghighi F; White S; Costa R; McMinn J; Chun K; Minden M; Tycko B
    Cancer Res; 2006 Apr; 66(7):3443-51. PubMed ID: 16585166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia.
    Alvarez S; Suela J; Valencia A; Fernández A; Wunderlich M; Agirre X; Prósper F; Martín-Subero JI; Maiques A; Acquadro F; Rodriguez Perales S; Calasanz MJ; Roman-Gómez J; Siebert R; Mulloy JC; Cervera J; Sanz MA; Esteller M; Cigudosa JC
    PLoS One; 2010 Aug; 5(8):e12197. PubMed ID: 20808941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients.
    Prieto-Conde MI; Corchete LA; García-Álvarez M; Jiménez C; Medina A; Balanzategui A; Hernández-Ruano M; Maldonado R; Sarasquete ME; Alcoceba M; Puig N; González-Calle V; García-Sanz R; Gutiérrez NC; González-Díaz M; Chillón MC
    J Mol Diagn; 2020 Jan; 22(1):60-71. PubMed ID: 31605801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats.
    Saied MH; Marzec J; Khalid S; Smith P; Down TA; Rakyan VK; Molloy G; Raghavan M; Debernardi S; Young BD
    PLoS One; 2012; 7(3):e33213. PubMed ID: 22479372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients.
    Achille NJ; Othus M; Phelan K; Zhang S; Cooper K; Godwin JE; Appelbaum FR; Radich JP; Erba HP; Nand S; Zeleznik-Le NJ
    Leuk Res; 2016 Mar; 42():68-74. PubMed ID: 26818573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling in acute myeloid leukemia.
    Bullinger L; Valk PJ
    J Clin Oncol; 2005 Sep; 23(26):6296-305. PubMed ID: 16155012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular signatures in acute myeloid leukemia.
    Mrózek K; Radmacher MD; Bloomfield CD; Marcucci G
    Curr Opin Hematol; 2009 Mar; 16(2):64-9. PubMed ID: 19468266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.
    Kadia TM; Ravandi F; Cortes J; Kantarjian H
    JAMA Oncol; 2015 Sep; 1(6):820-8. PubMed ID: 26181162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
    Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
    Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia.
    Claus R; Pfeifer D; Almstedt M; Zucknick M; Hackanson B; Plass C; Lübbert M
    Leuk Res; 2013 Feb; 37(2):190-6. PubMed ID: 23158571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
    Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
    Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
    Wouters BJ; Delwel R
    Blood; 2016 Jan; 127(1):42-52. PubMed ID: 26660432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease.
    Martignoles JA; Delhommeau F; Hirsch P
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular targeting in acute myeloid leukemia.
    Lim SH; Dubielecka PM; Raghunathan VM
    J Transl Med; 2017 Aug; 15(1):183. PubMed ID: 28851395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.